Gevo, Inc. (GEVO): Nasdaq/NYSE listing notice — Gevo receives Nasdaq delisting notice for bid price below $1.00

Gevo, Inc.

Nasdaq notified Gevo on Feb 29, 2024 of non-compliance with Minimum Bid Price Rule 5550(a)(2).
Common stock bid price has been below $1.00 for 30 consecutive business days.
Company has 180 calendar days, until Aug 27, 2024, to regain compliance by closing at $1.00+ for 10 days.
If not cured, Gevo may qualify for an additional 180-day period, possibly via reverse stock split.
No immediate impact on listing; trading continues under symbol GEVO.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Gevo, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

February 29, 2024, Gevo, Inc. (the “Company”) received notice from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company is not in compliance with Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”), as the minimum bid price of the Company’s common stock, par value $0.01 per share (the “Common Stock”), has been below $1.00 per share for the last 30 consecutive business days. The notice has no immediate effect on the listing or trading of the Common Stock on The Nasdaq Capital Market, and the Common Stock will continue to trade on The Nasdaq Capital Market under the symbol “G

View on SEC.gov

20 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Gevo, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-24-030480

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.